Filing Details
- Accession Number:
- 0001209191-22-025180
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-04-21 16:50:22
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2022-04-21 16:50:22
- Original Submission Date:
- 2021-08-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819411 | Gain Therapeutics Inc. | GANX | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1313876 | I Eric Richman | C/O Gain Therapeutics, Inc. 4800 Montgomery Lane, Suite 220 Bethesda MD 20814 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-16 | 4,922 | $7.87 | 216,820 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The original Form 4 filed on August 17, 2021 incorrectly listed the transaction code at "M" instead of "P".
Billionaire Hedge Funds
